FOXO4 DRI CAS 2460055 10 9 Peptide Manufacturer, API Supplier & Custom Synthesis SUNWAIN Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
foxo4-dri peptide senolytic study FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness